PM — Philip Morris International Inc.

Summary of PM Q1 2026 Earnings Call

1. Key Financial Results and Metrics

• Net Revenues: Over $10 billion, a 9% increase reported and 2.7% organic growth.
• Adjusted Operating Income (OI): Grew by 10% to $4.2 billion, with close to 1% organic growth.
• Adjusted Diluted Earnings Per Share (EPS): Increased by 16% to $1.96, benefiting from an $0.18 currency tailwind.
• Adjusted Gross Profit: Rose by 10% to $6.9 billion, with 3.8% organic growth and a 70 basis points organic gross margin expansion.
• International Smoke-Free Business: Achieved 11.9% volume growth, 15.8% net revenue growth, and 19.4% gross profit growth.

2. Strategic Updates and Business Highlights

• Strong performance in the international smoke-free segment, particularly from IQOS, which saw nearly 11% adjusted in-market sales growth.
• ZYN reached a joint #1 position in Europe, contributing to the multi-category strategy.
• Combustible business showed resilience with low single-digit organic growth despite cigarette volume declines.
• Continued investment in innovation and marketing for ZYN and IQOS, with plans for new product launches in the U.S. and international markets.
• Significant growth in e-vapor category VEEV, which became a leading brand in Europe.

3. Forward Guidance and Outlook

• Reaffirmed full-year expectations for organic net revenue growth of 5% to 7% and organic operating income growth of 7% to 9%.
• Adjusted diluted EPS forecasted at $8.36 to $8.51, reflecting a 10.9% to 12.9% growth in dollar terms.
• Anticipated sequential improvement in U.S. performance as comparisons normalize and new innovations are launched.

4. Bad News, Challenges, or Points of Concern

• U.S. nicotine pouch segment faced challenges with shipment declines due to inventory normalization and increased competition.
• Cigarette volume declines were at the higher end of expectations, reflecting a challenging economic environment and increased illicit consumption in some markets.
• Regulatory uncertainties surrounding nicotine pouches and potential excise tax increases in various states could impact future growth.
• Competitive pressures in the U.S. market, particularly for ZYN, as pricing strategies evolve.

5. Notable Q&A Insights

• Management expressed confidence in the U.S. ZYN segment's recovery, citing normalization of comparisons and anticipated innovations.
• Concerns were raised about the competitive landscape and pricing dynamics, with management emphasizing the importance of maintaining ZYN's premium positioning.
• Discussion on IQOS highlighted its strong brand equity and market share gains, particularly in Taiwan and Japan, despite potential disruptions from excise tax increases.
• Management acknowledged the impact of macroeconomic factors, including energy prices and geopolitical tensions, but maintained a positive long-term outlook for growth and transformation.

Overall, PM demonstrated a strong start to 2026, driven by robust international smoke-free performance, while navigating challenges in the U.S. market and regulatory landscape.